Tetsuji Nagano

Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study

W. Shimizu, M. Hori, T. Ikeda, 2014, Advances in Therapy.

Erratum to: Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study

W. Shimizu, M. Hori, T. Ikeda, 2014, Advances in Therapy.

Effect of Landiolol Hydrochloride on Hemodynamics in a Histamine-Induced Shock Model

Tetsuji Nagano, Tatsuaki Okamura, Masaharu Hirano, 2021, Drugs in R&D.

Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).

W. Shimizu, M. Hori, T. Ikeda, 2013, Circulation journal : official journal of the Japanese Circulation Society.

Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study

N. Matsuda, Yoshitsugu Yamada, H. Morimatsu, 2020, EClinicalMedicine.

Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.

N. Matsuda, Yoshitsugu Yamada, H. Morimatsu, 2020, The Lancet. Respiratory medicine.

Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.

K. Takigiku, H. Horigome, H. Ono, 2017, Journal of cardiology.